EPISODE · Aug 28, 2013 · 21 MIN
ACE to ARB
from Medicine and Science from The BMJ · host The BMJ
Should we screen for prostate cancer? A study published on bmj.com suggests that it doesn’t improve survival rates, and could lead to over treatment. Gabriel Sandblom, of the Karolinska Institute, tells us about his research. Also, James Ritter, emeritus professor of pharmacology at King’s College London, explains the As in the ABCD of hypertension treatment.
Embed this episode
NOW PLAYING
ACE to ARB
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.